Past, Present, and Future of Healthy Life Expectancy: Figure 1.
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The success of the current biomedical paradigm based on a "disease model" may be limited in the future because of large number of comorbidities inflicting older people. In recent years, there has been growing empirical evidence, based on animal models, suggesting that the aging process could be delayed and that this process may lead to increases in life expectancy accompanied by improvements in health at older ages. In this review, we explore past, present, and future prospects of healthy life expectancy and examine whether increases in average length of life associated with delayed aging link with additional years lived disability-free at older ages. Trends in healthy life expectancy suggest improvements among older people in the United States, although younger cohorts appear to be reaching old age with increasing levels of frailty and disability. Trends in health risk factors, such as obesity and smoking, show worrisome signs of negative impacts on adult health and mortality in the near future. However, results based on a simulation model of delayed aging in humans indicate that it has the potential to increase not only the length of life but also the fraction and number of years spent disability-free at older ages. Delayed aging would likely come with additional aggregate costs. These costs could be offset if delayed aging is widely applied and people are willing to convert their greater healthiness into more years of work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 4×
“With a few exceptions (see e.g., Goldman et al. 2013), most of the evidence of delayed aging is based on animal models and results show promising prospects for postponing the age at onset of chronic disease and disability accompanied by improved physiological status (Harrison et al., 2009).”
BackgroundInfluentialClearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 1×
“…caloric restriction (Anderson and Weindruch, 2012), single-gene mutations (Bartke, 2011), inhibitors of the target of rapamycin pathways (Miller et al., 2010), senescent cell elimination (Baker et al., 2011), and transplants of stem cells from young to old mice (Conboy et al., 2005), to name a few.”
Aging, natural death, and the compression of morbidity
Fries, J. F. (1980) · New England Journal of Medicine · doi:10.1056/nejm198007173030304 · Cited by 3,356
Verbrugge, L. M., & Jette, A. M. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90294-1 · Cited by 3,310
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612 · cited 2×
“Some research predicts a slow down of life expectancy as a result of obesity (Olshansky et al. 2005; Stewart et al. 2009), whereas there is compelling evidence that smoking has had a great toll on adult mortality and will likely continue to do so in the near future, at least for females (Preston et al.”
BackgroundRejuvenation of aged progenitor cells by exposure to a young systemic environment
Conboy, I. M., Conboy, M. J., Wagers, A. J., Girma, E. R., Weissman, I. L., & Rando, T. A. (2005) · Nature · doi:10.1038/nature03260 · Cited by 2,287
Prevalence of Dementia in the United States: The Aging, Demographics, and Memory Study
Plassman, B. L., Langa, K. M., Fisher, G. G., Heeringa, S. G., Weir, D. R., Ofstedal, M. B., Burke, J. R., Hurd, M. D., Potter, G. G., Rodgers, W. L., et al. (2007) · Neuroepidemiology · doi:10.1159/000109998 · Cited by 1,932 · cited 2×
“Moreover, it is estimated that the prevalence of dementia in the early 2000s at ages 71þ was 14% and 10% for Alzheimer’s disease specifically (Plassman et al. 2007), although some substantial portion of the increase is likely attributable to better diagnosis.”
Kirkwood, T. B. L., & Austad, S. N. (2000) · Nature · doi:10.1038/35041682 · Cited by 1,774
The Global Burden of Chronic Diseases: Overcoming Impediments to Prevention and Control
Yach, D., Hawkes, C., Gould, C. L., & Hofman, K. J. (2004) · JAMA · doi:10.1001/jama.291.21.2616 · Cited by 1,369 · cited 4×
“2Countries included: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Spain and the United Kingdom. the most (Yach et al., 2004).”
BackgroundInfluentialSeeman, T. E. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440400111013 · Cited by 1,368
Salomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881
Mortality and Morbidity Trends: Is There Compression of Morbidity?
Crimmins, E. M., & Beltran-Sanchez, H. (2011) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/gbq088 · Cited by 694 · cited 2×
“Data from early 2000s show stagnation and even deterioration in mobility functioning and disability (Crimmins and Beltrán-Sánchez, 2011; Freedman et al., 2013).”
BackgroundSelf-citationForecasting the effects of obesity and smoking on U.S. life expectancy
Stewart, S. T., Cutler, D. M., & Rosen, A. B. (2009) · New England Journal of Medicine · doi:10.1056/nejmsa0900459 · Cited by 478
Seeman, T. E., Merkin, S. S., Crimmins, E. M., & Karlamangla, A. S. (2010) · American Journal of Public Health · doi:10.2105/ajph.2008.157388 · Cited by 356 · cited 2×
“Additional evidence indicates increasing disability rates in recent years among younger American adults aged 40-64 years (Seeman et al., 2010).”
Self-citationPoverty and Biological Risk: The Earlier "Aging" of the Poor
Crimmins, E. M., Kim, J. K., & Seeman, T. E. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gln010 · Cited by 246 · cited 3×
“…social science research is quite recent, since the early 2000s, and has opened a new gate of possibilities for studying healthy aging and it is becoming the guide for current and future research on linking mortality improvements with health (Crimmins et al., 2009, 2010; Goldman et al., 2009, 2006).”
BackgroundSelf-citation
Cited by
Global Burden of Disease and the Impact of Mental and Addictive Disorders
Rehm, J., & Shield, K. D. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-0997-0 · Cited by 1,388
Obesity May Accelerate the Aging Process
Salvestrini, V., Sell, C., & Lorenzini, A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00266 · Cited by 260
“The question whether living longer represents more years of healthier life or an increase in years of disability is an important question (3, 4).”
BackgroundCrimmins, E. M., Zhang, Y. S., Kim, J. K., & Levine, M. E. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz075 · Cited by 37
“Because increased prevalence stems from either an increase in the incidence of disease or an increase in the length of time lived with disease, it is important to determine how incidence and mortality among people with diseases have changed, in order to identify the determinants of changes in observed prevalence as we…”
BackgroundSelf-citation
Metadata
- Authors
- Beltrán-Sánchez, H., Soneji, S., & Crimmins, E. M.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2015-11
- Volume
- 5
- Issue
- 11
- Pages
- a025957
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2181439874
- Cited by
- 151
- References
- 17
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.